ClinicalTrials.Veeva

Menu

mHealth for ART Adherence by HIV+ African Americans

E

Environment and Health Group

Status and phase

Completed
Phase 2

Conditions

HIV-1-infection

Treatments

Behavioral: On the Dot Mobile app

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT04557332
5R44MD007161-05

Details and patient eligibility

About

The objective of this grant is to create and test a mobile app to support ART adherence among HIV+ African American adults.

Full description

The Phase II project will enhance the existing (Phase 1) mobile intervention by offering: 1) a two-way communication capability through which participants can: i) indicate "pill taken" in response to pill reminders, and ii) receive a positive visual icon as behavioral-economics based reinforcement for "pill taken" responses; 2) pharmacist counseling and medication support; and, 3) the addition of educational and motivational text messages. Overall aims are to: 1) expand mhealth intervention to incorporate new Phase II features; 2) evaluate effectiveness in an RCT of HIV+ African Americans; and 3) prepare marketing and commercialization plans. Our long-term goal is to increase ART medication adherence, thus decreasing health disparities, among HIV+, African-Americans.

Enrollment

109 patients

Sex

All

Ages

30+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

(a) self-identify as African American, (b) age 30 or older, (c) HIV positive (d) currently on ART (e) report having problems with, and interest in improving their ART adherence (f) own a smartphone (g) report English as their primary language

Exclusion criteria

(a) not self-identified as African American, (b) under age 30 (c) HIV negative (d) not currently on ART (e) do not report having problems with, or interest in, improving their ART adherence (f) do not own a smartphone (g) do not report English as a primary language and (h) participating in another research study or clinical trial (i) receiving care at non-participating site and, (j) dementia diagnosis.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

109 participants in 2 patient groups

Mobile app
Experimental group
Description:
In this arm, participants received a mobile app to support ART medication adherence.
Treatment:
Behavioral: On the Dot Mobile app
Control
No Intervention group
Description:
In this arm, participants received care as usual.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems